ProfileGDS5678 / 1442106_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 16% 15% 15% 15% 15% 15% 16% 15% 15% 15% 15% 14% 15% 15% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 12.4101116
GSM967853U87-EV human glioblastoma xenograft - Control 22.3782515
GSM967854U87-EV human glioblastoma xenograft - Control 32.38115
GSM967855U87-EV human glioblastoma xenograft - Control 42.3211615
GSM967856U87-EV human glioblastoma xenograft - Control 52.3167515
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 12.4376715
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 22.4097616
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 32.3522715
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.3446515
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 12.3645615
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 22.3621515
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.3233314
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 42.3757615
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 52.3664815